Anti-vascular endothelial growth factor for diabetic macular oedema
Author:
Publisher
John Wiley & Sons, Ltd
Reference161 articles.
1. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial;Ahmadieh;Graefe's Archive for Clinical and Experimental Ophthalmology,2008
2. Azad R Sain S Sharma YR Mahajan D Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study Oman Journal of Ophthalmology 2012 166 70
3. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2;Michaelides;Ophthalmology,2010
4. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3;Rajendram;Archives of Ophthalmology,2012
5. Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT Study (Report 4);Sivaprasad;PloS ONE,2013
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of MicroRNA in linking diabetic retinal neurodegeneration and vascular degeneration;Frontiers in Endocrinology;2024-07-04
2. Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration;Canadian Journal of Ophthalmology;2024-06
3. Diabetic Retinopathy - Pathophysiology to Treatment: A Review;Current Diabetes Reviews;2024-01-22
4. Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema;Journal of Rawalpindi Medical College;2023-12-30
5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3